Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura D'Erasmo

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
Advances in Therapy|April 23, 2017
Efficacy of Lomitapide in the Treatment of Familial Homozygous Hypercholesterolemia: Results of a Real-World Clinical Experience in ItalyLaura D'Erasmo, Angelo Baldassare Cefalù, Davide Noto, et al.
JAMA Cardiology|February 14, 2024
Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial HypercholesterolemiaJanneke W C M Mulder, Tycho R Tromp, Mutaz Al-Khnifsawi, et al.
Circulation|September 15, 2023
ANGPTL3 Deficiency and Risk of Hepatic SteatosisLaura D'Erasmo, Michele Di Martino, Thomas Neufeld, et al.
Data in Brief|November 21, 2018
Characterisation of patients with familial chylomicronaemia syndrome (FCS) and multifactorial chylomicronaemia syndrome (MCS): Establishment of an FCS clinical diagnostic scorePhilippe Moulin, Robert Dufour, Maurizio Averna, et al.
Atherosclerosis|July 7, 2018
Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): Expert panel recommendations and proposal of an "FCS score"Philippe Moulin, Robert Dufour, Maurizio Averna, et al.
Orphanet Journal of Rare Diseases|September 9, 2021
Long-term efficacy of lipoprotein apheresis and lomitapide in the treatment of homozygous familial hypercholesterolemia (HoFH): a cross-national retrospective surveyLaura D'Erasmo, Antonio Gallo, Angelo Baldassare Cefalù, et al.
Journal of the American College of Cardiology|January 20, 2018
Autosomal Recessive Hypercholesterolemia: Long-Term Cardiovascular OutcomesLaura D'Erasmo, Ilenia Minicocci, Antonio Nicolucci, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
Advances in Therapy|April 23, 2017
Efficacy of Lomitapide in the Treatment of Familial Homozygous Hypercholesterolemia: Results of a Real-World Clinical Experience in ItalyLaura D'Erasmo, Angelo Baldassare Cefalù, Davide Noto, et al.
JAMA Cardiology|February 14, 2024
Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial HypercholesterolemiaJanneke W C M Mulder, Tycho R Tromp, Mutaz Al-Khnifsawi, et al.
Circulation|September 15, 2023
ANGPTL3 Deficiency and Risk of Hepatic SteatosisLaura D'Erasmo, Michele Di Martino, Thomas Neufeld, et al.
Data in Brief|November 21, 2018
Characterisation of patients with familial chylomicronaemia syndrome (FCS) and multifactorial chylomicronaemia syndrome (MCS): Establishment of an FCS clinical diagnostic scorePhilippe Moulin, Robert Dufour, Maurizio Averna, et al.
Atherosclerosis|July 7, 2018
Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): Expert panel recommendations and proposal of an "FCS score"Philippe Moulin, Robert Dufour, Maurizio Averna, et al.
Orphanet Journal of Rare Diseases|September 9, 2021
Long-term efficacy of lipoprotein apheresis and lomitapide in the treatment of homozygous familial hypercholesterolemia (HoFH): a cross-national retrospective surveyLaura D'Erasmo, Antonio Gallo, Angelo Baldassare Cefalù, et al.
Journal of the American College of Cardiology|January 20, 2018
Autosomal Recessive Hypercholesterolemia: Long-Term Cardiovascular OutcomesLaura D'Erasmo, Ilenia Minicocci, Antonio Nicolucci, et al.
Pageof 8